Q4 2024 Earnings Call Transcript March 17, 2025 FibroGen, Inc. reports earnings inline with expectations. Reported EPS is $-0 ...

Since his initial candidacy in 2015, the mainstream media and Uniparty establishment have asserted that Donald Trump is a divisive figure who has fractured the nation. Whether a president is a uniter ...

Arkansas lawmakers are once again considering House Bill 1668, addressing gender-affirming care for transgender youth.

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

DISCLAIMER: All suspects are presumed innocent until proven guilty. SHREVEPORT, La. (KTAL/KMSS) — The Shreveport Police ...

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Apalutamide tablets, 60 mg.

On Wednesday, 3018 stocks advanced, 1033 declined and 115 remained unchanged, with an advance decline ratio of 2.92 on the ...

Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture Apalutamide Tablets, 60 mg. However, the stock came off highs to trade 0.9% ...

Do you live in the countryside in Spain and fancy having your own chickens, cows and/or sheep? Unfortunately, even this ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...